Statins, diabetes, obesity, nonalcoholic fatty liver disease, and hepatocellular carcinoma

Hepatobiliary Pancreat Dis Int. 2019 Apr;18(2):202. doi: 10.1016/j.hbpd.2018.10.004. Epub 2018 Nov 16.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Carcinoma, Hepatocellular*
  • Diabetes Mellitus*
  • Hepacivirus
  • Hepatitis B virus
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors*
  • Liver Cirrhosis
  • Liver Neoplasms*
  • Non-alcoholic Fatty Liver Disease*
  • Obesity

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors